ResearchMoz

The Politics of Pharma - Washington, States and the Courts Impact on the Industry

CBR Pharma Insights
Published Date » 2013-04-15
No. Of Pages » 49
Politics have a greater direct effect on the pharmaceutical industry than almost any other in the US, and correspondingly, pharma makes considerable investments in election campaigns. The November elections kept the face of Washington the same, with the re-election of President Obama, Democratic control of the Senate and Republican control of the House. However, the outcome of the elections will still impact the industry in a variety of ways.  The Medical Device Excise Tax, a component of the 2010 health care reform legislation, survived a pre-election Congressional effort at repeal, but a coalition of House Republicans and Democrats from key states are looking to try again. Post-election, another bi-partisan congressional group is pushing for the FDA to impose stricter regulations on...
Executive Summary

Chapter 1: November Election Results
Pharmas investment in the elections
Election results
Medical device tax
Congressional spotlight on painkillers
The FDA

Chapter 2: Health Care Reform
Implementation
The Sunshine Act
Meaningful use debate

Chapter 3: State Politics
State Health Care Exchanges
Biosimilar substitution

Chapter 4: The Courts
Pay-for-delay
Generics liability
Reform
Off-label use

Chapter 5: The Political Outlook
Impact of the budget impasse
Medicare
Indian trade issues
The CBR View

Appendix

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Greece: molluscs market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the molluscs market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the molluscs market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
Tissue Engineering And Organ Regeneration Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Tissue engineering and organ regeneration market encompasses those products used in medicine. The application of these new age biomaterials include burn treatment or wound care, orthopaedics, urological products, and neurology products. Engineered cell growth has been present over the past many years with little or no applications in medicine. Recent developments and progress in the field of stem cell technology, cell culture technology and immunopassivation and immunomodulation has provided incredible opportunities to market players. Several cardiovascular applications such as heart valve...
Asia Interlinings & Linings Industry 2014 Market Research Report
By - QYResearch
Asia Interlinings & Linings Industry 2014 Market Research Report

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Pepsi Limon, A Brand New Addition to the Pepsi Portfolio
May 22, 2015  
To add a new dose of excitement to its cola offering, Pepsi has come up with the all new Pepsi Limon. This is a new flavored cola, which according to the company is manufactured with just the appropriate amount of real lime juice. The idea for the drink was inspired from the escalating preference of the Hispanic consumers. To satisfy the taste urges of the consumers, the new Pepsi Limon will...
Chinese Everbright Healthcare Fund to Acquire U.S. Firm Ambrx
May 22, 2015  
A group led by Chinese healthcare fund Everbright has chalked out details to buy U.S. based biotechnology firm Ambrx for an amount which in undisclosed. The deal, recently announces, is inclusive of other healthcare companies in mainland which are WuXi Pharma Tech and Shanghai Fosun Pharmaceutical, and investment company HOPU Investments.  The deal, which requires...
India’s Auto Exports Register Record High Figures in 2014-15
May 21, 2015  
In the fiscal year 2014-15, Indian factories exported a record number of 3.5 million vehicles, which is 15% higher than what they managed a year back. However, domestic sales rose by only 5% since last financial year, with 2.6 million units being sold.  Exports of utility vehicles, commercial vehicles, cars and two- wheelers have increased every year since 2000. But domestic car...
Turkey’s Labor Dispute Affects Ford’s Production
May 21, 2015  
With the ongoing labor dispute in Turkey, Ford’s Turkish manufacturing facility has been hit. Ford Otosan, a joint venture between the company and Turkey’s Koc Holding, mentioned that due to supply problems, production has been temporary stalled at its plants located at Yenikoy and Golcuk in northwestern part of the country. Earlier this week, production at Tofas and Oyak Renault,...
International Automakers Slashing Prices in China
May 21, 2015  
With a slowing Chinese economy, the international automakers are cutting prices of vehicles to be sold in the nation. This has hit the profit margins of the automakers who are struggling with a slowdown in demand.  Last week saw Ford Motor Co. and General Motors slashing their prices on Chinese models. It closely follows rival Volkswagen AG’s move last month to offer...